According to the self-nonself model of immunity, allogeneic T cells are considered as major cause of graft versus host disease (GVHD) following allogeneic stem cell transplantation (SCT). On the other hand, the danger model of immunity suggests that transplant-associated recipient tissue injury rather than donor-derived alloreactive T cells is the main cause of GVHD. What has been less appreciated are the early, both conditioning-dependent and conditioning-independent, events that impair homeostatic cellular adaptations and host-protective immune responses leading to the development of tissue-specific GVHD. The notion of gut injury precipitating in GVHD has been acknowledged by clinicians, with the shift to reduced intensity-conditioning re...
peer reviewedAllogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immun...
Chronic graft-versus-host disease (GVHD) is the most common cause of poor long-term outcomes after a...
Allogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immunotherapy agai...
According to the self-nonself model of immunity, allogeneic T cells are considered as major cause of...
The use of allogeneic hematopoietic cell transplantation (HCT) has increased as new techniques have ...
Graft-vs-host disease (GVHD) is the most common cause of non-relapse mortality following allogeneic ...
AbstractThe pathophysiology of acute graft-versus-host disease (GVHD) remains poorly understood in h...
Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for hematologic malig...
The success of allogeneic hematopoietic cell transplantation depends heavily on the delicate balance...
The graft-versus-host reaction (GVHR) in both mice and humans can lead to the development of a broad...
Alloreactivity after transplantation is associated with profound immune suppression, and consequent ...
Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic cell trans...
Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic cell trans...
peer reviewedAllogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immun...
Alloreactivity after transplantation is associated with profound immune suppression, and consequent ...
peer reviewedAllogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immun...
Chronic graft-versus-host disease (GVHD) is the most common cause of poor long-term outcomes after a...
Allogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immunotherapy agai...
According to the self-nonself model of immunity, allogeneic T cells are considered as major cause of...
The use of allogeneic hematopoietic cell transplantation (HCT) has increased as new techniques have ...
Graft-vs-host disease (GVHD) is the most common cause of non-relapse mortality following allogeneic ...
AbstractThe pathophysiology of acute graft-versus-host disease (GVHD) remains poorly understood in h...
Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for hematologic malig...
The success of allogeneic hematopoietic cell transplantation depends heavily on the delicate balance...
The graft-versus-host reaction (GVHR) in both mice and humans can lead to the development of a broad...
Alloreactivity after transplantation is associated with profound immune suppression, and consequent ...
Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic cell trans...
Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic cell trans...
peer reviewedAllogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immun...
Alloreactivity after transplantation is associated with profound immune suppression, and consequent ...
peer reviewedAllogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immun...
Chronic graft-versus-host disease (GVHD) is the most common cause of poor long-term outcomes after a...
Allogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immunotherapy agai...